Phase I trial of INSYS Therapeutics' cannabidiol in adults
Phase of Trial: Phase I
Latest Information Update: 11 Nov 2014
Price : $35 *
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Adverse reactions; First in man
- Sponsors INSYS Pharma
- 11 Nov 2014 This phase I dose-ranging study will be conducted prior to phase III trials in Lennox-Gastaut and Dravet Syndrome, planned for 2015, according to an Insys Therapeutics media release.
- 15 Oct 2014 The first human subject is expected to be dosed with cannabidiol in the first quarter of 2015, according to an Insys Therapeutics media release.
- 12 May 2014 New trial record